MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1097/adm.0000000000001297

Медицинская библиотека · Journal of addiction medicine · 2024

Contemporary Management and Outcomes of Veterans Hospitalized With Alcohol Withdrawal: A Multicenter Retrospective Cohort Study.

Ronan Matthew V, Gordon Kirsha S, Skanderson Melissa, Krug Michael, Godwin Patrick, Heppe Daniel, Hoegh Matthew, Boggan Joel C, Gutierrez Jeydith, Kaboli Peter, Pescetto Micah, Guidry Michelle, Caldwell Peter, Mitchell Christine, Ehlers Erik, Allaudeen Nazima, Cyr Jessica, Smeraglio Andrea, Yarbrough Peter, Rose Richard, Jagannath Anand, Vargas Jaclyn, Cornia Paul B, Shah Meghna, Tuck Matthew, Arundel Cherinne, Laudate James, Elzweig Joel, Rodwin Benjamin, Akwe Joyce, Trubitt Meredith, Gunderson Craig G

СтатьяМногоцентровое исследованиеПоддержка правительства СШАПеревод в очереди

Аннотация

OBJECTIVES

Few studies describe contemporary alcohol withdrawal management in hospitalized settings or review current practices considering the guidelines by the American Society of Addiction Medicine (ASAM).

METHODS

We conducted a retrospective cohort study of patients hospitalized with alcohol withdrawal on medical or surgical wards in 19 Veteran Health Administration (VHA) hospitals between October 1, 2018, and September 30, 2019. Demographic and comorbidity data were obtained from the Veteran Health Administration Corporate Data Warehouse. Inpatient management and hospital outcomes were obtained by chart review. Factors associated with treatment duration and complicated withdrawal were examined.

RESULTS

Of the 594 patients included in this study, 51% were managed with symptom-triggered therapy alone, 26% with fixed dose plus symptom-triggered therapy, 10% with front loading regimens plus symptom-triggered therapy, and 3% with fixed dose alone. The most common medication given was lorazepam (87%) followed by chlordiazepoxide (33%), diazepam (14%), and phenobarbital (6%). Symptom-triggered therapy alone (relative risk [RR], 0.68; 95% confidence interval [CI], 0.57-0.80) and front loading with symptom-triggered therapy (RR, 0.75; 95% CI, 0.62-0.92) were associated with reduced treatment duration. Lorazepam (RR, 1.20; 95% CI, 1.02-1.41) and phenobarbital (RR, 1.28; 95% CI, 1.06-1.54) were associated with increased treatment duration. Lorazepam (adjusted odds ratio, 4.30; 95% CI, 1.05-17.63) and phenobarbital (adjusted odds ratio, 6.51; 95% CI, 2.08-20.40) were also associated with complicated withdrawal.

CONCLUSIONS

Overall, our results support guidelines by the ASAM to manage patients with long-acting benzodiazepines using symptom-triggered therapy. Health care systems that are using shorter acting benzodiazepines and fixed-dose regimens should consider updating alcohol withdrawal management pathways to follow ASAM recommendations.

Для цитирования: Ronan Matthew V, Gordon Kirsha S, Skanderson Melissa, Krug Michael, Godwin Patrick, Heppe Daniel, Hoegh Matthew, Boggan Joel C, Gutierrez Jeydith, Kaboli Peter, Pescetto Micah, Guidry Michelle, Caldwell Peter, Mitchell Christine, Ehlers Erik, Allaudeen Nazima, Cyr Jessica, Smeraglio Andrea, Yarbrough Peter, Rose Richard, Jagannath Anand, Vargas Jaclyn, Cornia Paul B, Shah Meghna, Tuck Matthew, Arundel Cherinne, Laudate James, Elzweig Joel, Rodwin Benjamin, Akwe Joyce, Trubitt Meredith, Gunderson Craig G. Contemporary Management and Outcomes of Veterans Hospitalized With Alcohol Withdrawal: A Multicenter Retrospective Cohort Study.. Journal of addiction medicine. 2024. DOI: 10.1097/adm.0000000000001297.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.